![](/accounts/isop/images/logo.png)
How to Prepare for a Successful MIDD Meeting with the FDA
Includes a Live Web Event on 12/18/2024 at 12:00 PM (EST)
-
You must log in to register
- Member - Free!
Overview of the 2024 MIDD Webinar Series
The 2024 MIDD Webinar Series, coordinated by Ana Ruiz and Sihem Bihorel, is a series of webinars focused on shaping the future of drug development and regulatory decision-making. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases. Topics range from regulatory aspects from a European perspective to methods for dose selection in rare diseases.
![Speaker image](https://482ddb490551e34045b1-2722ce6458a1eafa0a49e430ba6315ed.ssl.cf2.rackcdn.com/isop_d3d915b7f8ff11fd08833a0ef22a0a09.png)
Joga Gobburu
CEO
Pumas-AI, Inc.
Dr. Gobburu is a scientist in drug development. He is best known for transforming the field of pharmacometrics into a decision-supporting science. His experience as a senior biomedical research scientist and Director of Pharmacometrics at the Food and Drug Administration (FDA) gives him unique insight into the technical, regulatory, and decision-making aspects in all phases of drug development. He obtained his BPharm and MSc in chemistry from the Birla Institute of Technology and Science, his Ph.D. in pharmaceutical sciences from North Dakota State University, and his MBA from Johns Hopkins University. Dr Gobburu co-founded Pumas-AI Inc. and Vivpro Corporation.